Latest news
Loading news…
SAGE Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2010 251-500 employees For Profit
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
SAGE Therapeutics was acquired by Supernus Pharmaceuticals in 2025 for $561M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
631
Ticker
SAGE
NASDAQ
Patents
199
23 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- SAGE
- Exchange
- NASDAQ
- IPO date
- Jul 18, 2014
- Raised at IPO
- $90M
- Valuation at IPO
- $103.5M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
- Mobile apps
- 4
- Active products
- 18
- Patents granted
- 199
- Trademarks
- 23
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $895.12K
Company Info
- Founded
- 2010
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 341
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jul 18, 2014
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.3
- Trend (90d)
- 0
- Last leadership hire
- Aug 1, 2025
- Last layoff mention
- Aug 1, 2025
Key People at SAGE Therapeutics
Board Member, Start-Up CEO
CEO
CFO
Chief Medical Officer
Scientific Advisors
Co-Founder
Scientific Advisors
Scientific Advisors
Vice President and Head of Cybersecurity
Senior Vice President, General Counsel
Senior Vice President, People and Organizational Strategy
631
professional contacts at SAGE Therapeutics
Contact execs at SAGE Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to SAGE Therapeutics
Loading news…
FAQs about SAGE Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.